KMT2B and invasive breast carcinoma: As reported by Natarajan et al., MLL2 upregulation within BC cells was related to tissue malignancy; meanwhile, MLL2 protein upregulation was also detected in tissues from patients with breast invasive carcinomas (Natarajan et al., 2010).